These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12236347)

  • 1. Estrogen receptor binding assay method for endocrine disruptors using fluorescence polarization.
    Ohno K; Fukushima T; Santa T; Waizumi N; Tokuyama H; Maeda M; Imai K
    Anal Chem; 2002 Sep; 74(17):4391-6. PubMed ID: 12236347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on interactions of endocrine disruptors with estrogen receptor using fluorescence polarization.
    Ohno K; Suzuki S; Fukushima T; Maeda M; Santa T; Imai K
    Analyst; 2003 Aug; 128(8):1091-6. PubMed ID: 12964612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on interactions of endocrine disruptors with estrogen receptor-beta using fluorescence polarization.
    Suzuki S; Ohno K; Santa T; Imai K
    Anal Sci; 2003 Aug; 19(8):1103-8. PubMed ID: 12945660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.
    Parker GJ; Law TL; Lenoch FJ; Bolger RE
    J Biomol Screen; 2000 Apr; 5(2):77-88. PubMed ID: 10803607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening assays for estrogen receptor by using coumestrol, a natural fluorescence compound.
    Wang C; Li C; Zhou H; Huang J
    J Biomol Screen; 2014 Feb; 19(2):253-8. PubMed ID: 24019253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding Assays Using a Benzofurazan-Labeled Fluorescent Probe for Estrogen Receptor-Ligand Interactions.
    Komatsu S; Ohno KI; Fujimura T
    Chem Pharm Bull (Tokyo); 2020; 68(10):954-961. PubMed ID: 32999147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
    Sasson S; Notides AC
    Mol Endocrinol; 1988 Apr; 2(4):307-12. PubMed ID: 3380103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estriol and estrone interaction with the estrogen receptor. II. Estriol and estrone-induced inhibition of the cooperative binding of [3H]estradiol to the estrogen receptor.
    Sasson S; Notides AC
    J Biol Chem; 1983 Jul; 258(13):8118-22. PubMed ID: 6863280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta.
    Margeat E; Bourdoncle A; Margueron R; Poujol N; Cavaillès V; Royer C
    J Mol Biol; 2003 Feb; 326(1):77-92. PubMed ID: 12547192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain.
    Hawkins MB; Thomas P
    Endocrinology; 2004 Jun; 145(6):2968-77. PubMed ID: 15001543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct measure of fluorescence intensity for efficient receptor-binding assay: conjugates of ethinylcarboxyestradiol and 5(and 6)-carboxyfluorescein via alpha, omega-diaminoalkanes as a tracer for estrogen receptor.
    Asai D; Tokunaga T; Kondo K; Kawaguchi T; Takayanagi S; Shinmyozu T; Nakai M; Yakabe Y; Shimohigashi Y
    J Biochem; 2008 Jun; 143(6):781-92. PubMed ID: 18316331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estriol and estrone interaction with the estrogen receptor. I. Temperature-induced modulation of the cooperative binding of [3H]estriol and [3H]estrone to the estrogen receptor.
    Sasson S; Notides AC
    J Biol Chem; 1983 Jul; 258(13):8113-7. PubMed ID: 6863279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrochemical evaluation of the interaction between endocrine disrupter chemicals and estrogen receptor using 17,beta-estradiol labeled with daunomycin.
    Kuramitz H; Natsui J; Sugawara K; Itoh S; Tanaka S
    Anal Chem; 2002 Feb; 74(3):533-8. PubMed ID: 11838671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estriol-induced inhibition of the estrogen receptor's positive cooperativity.
    Sasson S; Notides AC
    J Steroid Biochem; 1984 Apr; 20(4B):1021-6. PubMed ID: 6727346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
    Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of synthetic estrogens with human estrogen receptors.
    Nikov GN; Eshete M; Rajnarayanan RV; Alworth WL
    J Endocrinol; 2001 Jul; 170(1):137-45. PubMed ID: 11431146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
    Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-ring nitro- and amino-substituted estradiol analogs produce a negative cooperative or noncooperative [3H]estradiol-estrogen receptor binding mechanism.
    Schwartz JA; Skafar DF
    Biochemistry; 1994 Nov; 33(45):13267-73. PubMed ID: 7947734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.
    Kuiper GG; Carlsson B; Grandien K; Enmark E; Häggblad J; Nilsson S; Gustafsson JA
    Endocrinology; 1997 Mar; 138(3):863-70. PubMed ID: 9048584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.